SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

Anthropic considers new model to counter OpenAI’s latest AI push

Google’s Gemini hacked real companies during a cyber test linked to Israeli startup Irregular

Israel’s consumer advantage is changing

Slowing AI isn’t a defense strategy

Buzz

Most popular

Daily

Weekly

1

Serbia opens Israeli drone factory as defense ties with Elbit deepen

2

“Our next milestone will be a billion-dollar valuation”: MIND triples valuation to $300 million with $72 million Series B

3

The man who helped build Palo Alto’s Cortex is leaving the company

4

How an Israeli engineer went from Rafael to iPhone Portrait Mode and a $300 million OpenAI exit

5

Sayeret Matkal veterans raise $22 million to teach the world English with AI

Rimsa

3 stories about Rimsa

Israeli court documents reveal worrying details on Teva’s decision to acquire Mexico’s Rimsa

08.06.20|Sophie Shulman

Classified documents show that Teva's board of directors didn't even dedicate a full meeting to the acquisition

מטה חברת טבע תרופות

Derivative Suit Sheds Light on Teva’s Disastrous Rimsa Acquisition

28.05.19|Hezi Sternlicht

Teva acquired Mexican drugmaker Rimsa in 2016, but an anonymous email sent a week after the deal’s completion led Teva to launch an internal investigation—and sue the sellers for fraud

Teva and Rimsa Settle Contested $2.3-Billion Acquisition Deal Out of Court

10.04.18|Dror Reich

Teva acquired the Mexican plant in 2016 but shut it down immediately, citing discrepancies between Rimsa's regulatory filing and the actual assets, and filed a suit against the former owners